120 related articles for article (PubMed ID: 33500241)
1. Mutation in the distal NPxY motif of LRP1 alleviates dietary cholesterol-induced dyslipidemia and tissue inflammation.
Jaeschke A; Haller A; Cash JG; Nam C; Igel E; Roebroek AJM; Hui DY
J Lipid Res; 2021; 62():100012. PubMed ID: 33500241
[TBL] [Abstract][Full Text] [Related]
2. Low-density lipoprotein receptor-related protein-1 dysfunction synergizes with dietary cholesterol to accelerate steatohepatitis progression.
Hamlin AN; Chinnarasu S; Ding Y; Xian X; Herz J; Jaeschke A; Hui DY
J Biol Chem; 2018 Jun; 293(25):9674-9684. PubMed ID: 29752404
[TBL] [Abstract][Full Text] [Related]
3. Synergistic interaction of dietary cholesterol and dietary fat in inducing experimental steatohepatitis.
Savard C; Tartaglione EV; Kuver R; Haigh WG; Farrell GC; Subramanian S; Chait A; Yeh MM; Quinn LS; Ioannou GN
Hepatology; 2013 Jan; 57(1):81-92. PubMed ID: 22508243
[TBL] [Abstract][Full Text] [Related]
4. Menhaden oil decreases high-fat diet-induced markers of hepatic damage, steatosis, inflammation, and fibrosis in obese Ldlr-/- mice.
Depner CM; Torres-Gonzalez M; Tripathy S; Milne G; Jump DB
J Nutr; 2012 Aug; 142(8):1495-503. PubMed ID: 22739374
[TBL] [Abstract][Full Text] [Related]
5. Mutant Lrp1 knock-in mice generated by recombinase-mediated cassette exchange reveal differential importance of the NPXY motifs in the intracellular domain of LRP1 for normal fetal development.
Roebroek AJ; Reekmans S; Lauwers A; Feyaerts N; Smeijers L; Hartmann D
Mol Cell Biol; 2006 Jan; 26(2):605-16. PubMed ID: 16382151
[TBL] [Abstract][Full Text] [Related]
6. Estrogen deficiency worsens steatohepatitis in mice fed high-fat and high-cholesterol diet.
Kamada Y; Kiso S; Yoshida Y; Chatani N; Kizu T; Hamano M; Tsubakio M; Takemura T; Ezaki H; Hayashi N; Takehara T
Am J Physiol Gastrointest Liver Physiol; 2011 Dec; 301(6):G1031-43. PubMed ID: 21885686
[TBL] [Abstract][Full Text] [Related]
7. Overactivation of intestinal sterol response element-binding protein 2 promotes diet-induced nonalcoholic steatohepatitis.
Malhotra P; Aloman C; Ankireddy A; Khadra H; Ooka K; Gill RK; Saksena S; Dudeja PK; Alrefai WA
Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G376-G385. PubMed ID: 28774869
[TBL] [Abstract][Full Text] [Related]
8. Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis.
Wouters K; van Gorp PJ; Bieghs V; Gijbels MJ; Duimel H; Lütjohann D; Kerksiek A; van Kruchten R; Maeda N; Staels B; van Bilsen M; Shiri-Sverdlov R; Hofker MH
Hepatology; 2008 Aug; 48(2):474-86. PubMed ID: 18666236
[TBL] [Abstract][Full Text] [Related]
9. The adaptor protein PID1 regulates receptor-dependent endocytosis of postprandial triglyceride-rich lipoproteins.
Fischer AW; Albers K; Krott LM; Hoffzimmer B; Heine M; Schmale H; Scheja L; Gordts PLSM; Heeren J
Mol Metab; 2018 Oct; 16():88-99. PubMed ID: 30100244
[TBL] [Abstract][Full Text] [Related]
10. Cholic acid supplementation accelerates the progression of nonalcoholic fatty liver disease to the procarcinogenic state in mice fed a high-fat and high-cholesterol diet.
Chun HJ; Shim YJ; Kwon YH
J Nutr Biochem; 2022 Feb; 100():108869. PubMed ID: 34563665
[TBL] [Abstract][Full Text] [Related]
11. Hepatic remnant lipoprotein clearance by heparan sulfate proteoglycans and low-density lipoprotein receptors depend on dietary conditions in mice.
Foley EM; Gordts PLSM; Stanford KI; Gonzales JC; Lawrence R; Stoddard N; Esko JD
Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2065-74. PubMed ID: 23846497
[TBL] [Abstract][Full Text] [Related]
12. Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice.
Subramanian S; Goodspeed L; Wang S; Kim J; Zeng L; Ioannou GN; Haigh WG; Yeh MM; Kowdley KV; O'Brien KD; Pennathur S; Chait A
J Lipid Res; 2011 Sep; 52(9):1626-35. PubMed ID: 21690266
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of the proximal NPXY motif impairs early steps in LRP1 biosynthesis.
Reekmans SM; Pflanzner T; Gordts PL; Isbert S; Zimmermann P; Annaert W; Weggen S; Roebroek AJ; Pietrzik CU
Cell Mol Life Sci; 2010 Jan; 67(1):135-45. PubMed ID: 19856143
[TBL] [Abstract][Full Text] [Related]
14. Deficiency of LRP1 in Mature Adipocytes Promotes Diet-Induced Inflammation and Atherosclerosis-Brief Report.
Konaniah ES; Kuhel DG; Basford JE; Weintraub NL; Hui DY
Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1046-1049. PubMed ID: 28473440
[TBL] [Abstract][Full Text] [Related]
15. Dietary modification dampens liver inflammation and fibrosis in obesity-related fatty liver disease.
Larter CZ; Yeh MM; Haigh WG; Van Rooyen DM; Brooling J; Heydet D; Nolan CJ; Teoh NC; Farrell GC
Obesity (Silver Spring); 2013 Jun; 21(6):1189-99. PubMed ID: 23666886
[TBL] [Abstract][Full Text] [Related]
16. Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites.
Zhang X; Coker OO; Chu ES; Fu K; Lau HCH; Wang YX; Chan AWH; Wei H; Yang X; Sung JJY; Yu J
Gut; 2021 Apr; 70(4):761-774. PubMed ID: 32694178
[TBL] [Abstract][Full Text] [Related]
17. Macrophage LRP1 Promotes Diet-Induced Hepatic Inflammation and Metabolic Dysfunction by Modulating Wnt Signaling.
Au DT; Migliorini M; Strickland DK; Muratoglu SC
Mediators Inflamm; 2018; 2018():7902841. PubMed ID: 30524198
[TBL] [Abstract][Full Text] [Related]
18. High fat / high cholesterol diet does not provoke atherosclerosis in the ω3-and ω6-polyunsaturated fatty acid synthesis-inactivated Δ6-fatty acid desaturase-deficient mouse.
Stoffel W; Binczek E; Schmidt-Soltau I; Brodesser S; Wegner I
Mol Metab; 2021 Dec; 54():101335. PubMed ID: 34530175
[TBL] [Abstract][Full Text] [Related]
19. Vertical Sleeve Gastrectomy Attenuates the Progression of Non-Alcoholic Steatohepatitis in Mice on a High-Fat High-Cholesterol Diet.
Whang E; Liu Y; Kageyama S; Woo SL; Yang J; Lee R; Li Z; Ji H; Chen Y; Kupiec-Weglinski JW
Obes Surg; 2019 Aug; 29(8):2420-2429. PubMed ID: 30982168
[TBL] [Abstract][Full Text] [Related]
20. FGF21 protects against hepatic lipotoxicity and macrophage activation to attenuate fibrogenesis in nonalcoholic steatohepatitis.
Liu C; Schönke M; Spoorenberg B; Lambooij JM; van der Zande HJP; Zhou E; Tushuizen ME; Andreasson AC; Park A; Oldham S; Uhrbom M; Ahlstedt I; Ikeda Y; Wallenius K; Peng XR; Guigas B; Boon MR; Wang Y; Rensen PCN
Elife; 2023 Jan; 12():. PubMed ID: 36648330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
